🔗 Share this article Social Media Content Creators Driving Parallel Trade for Unlicensed Slimming Drug A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings. Experimental Drug Gaining Popularity Via Social Media The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to message these accounts privately for source information, while also receiving promotional offers. Active Trade on Social Networks Separately, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing buyers to WhatsApp for transactions. Learning About Retatrutide This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic. Healthcare Professionals Express Concerns Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users administering substances of unknown origin. Some professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro. Regulatory Position and Implementation Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations. Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment. Platform Reaction and Content Removal According to TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures. Online Trading Operations Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence. After minutes of joining one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience. Product Information and Costs Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.” Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Service Oversight and Safety Actions A representative for Telegram said it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U. A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained. Her team has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.” Manufacturer Statement A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially serious health risks”.